Celadon Pharmaceuticals (LSE:CEL) Short-Term Debt : £0.02 Mil (As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Celadon Pharmaceuticals Short-Term Debt?

Celadon Pharmaceuticals's Short-Term Debt for the quarter that ended in Jun. 2024 was £0.02 Mil.

Celadon Pharmaceuticals's quarterly Short-Term Debt increased from Jun. 2023 (£0.01 Mil) to Dec. 2023 (£0.02 Mil) and increased from Dec. 2023 (£0.02 Mil) to Jun. 2024 (£0.02 Mil).

Celadon Pharmaceuticals's annual Short-Term Debt increased from Dec. 2021 (£0.00 Mil) to Dec. 2022 (£0.01 Mil) and increased from Dec. 2022 (£0.01 Mil) to Dec. 2023 (£0.02 Mil).

Celadon Pharmaceuticals Short-Term Debt Historical Data

The historical data trend for Celadon Pharmaceuticals's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celadon Pharmaceuticals Short-Term Debt Chart

Celadon Pharmaceuticals Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Debt

0.01

0.02

Celadon Pharmaceuticals Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Short-Term Debt	Get a 7-Day Free Trial					0.01	0.01	0.01	0.02	0.02

Celadon Pharmaceuticals Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Celadon Pharmaceuticals Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Celadon Pharmaceuticals's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Celadon Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Celadon Pharmaceuticals PLC (LSE:CEL) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

32-33 Cowcross Street, London, GBR, EC1M 6DF

Website

https://www.celadonpharma.co.uk

Celadon Pharmaceuticals PLC focuses on growing indoor hydroponic high-quality cannabis initially for use within the chronic pain market. It has two reportable segments Celadon is a Build of grow facilities, growing medical grade cannabis and research in the GMP lab, and Harley Street (CPC) is a clinical study into the pain relief benefits of medicinal cannabis. It operates only in the UK and has only one geographical area.

Celadon Pharmaceuticals Headlines

No Headlines